These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28949048)

  • 1. Regional analysis and genetic association of nigrostriatal degeneration in Lewy body disease.
    Kasanuki K; Heckman MG; Diehl NN; Murray ME; Koga S; Soto A; Ross OA; Dickson DW
    Mov Disord; 2017 Nov; 32(11):1584-1593. PubMed ID: 28949048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of MAPT H1 subhaplotypes with neuropathology of lewy body disease.
    Heckman MG; Kasanuki K; Brennan RR; Labbé C; Vargas ER; Soto AI; Murray ME; Koga S; Dickson DW; Ross OA
    Mov Disord; 2019 Sep; 34(9):1325-1332. PubMed ID: 31234228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?
    Tsuboi Y; Dickson DW
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S47-51. PubMed ID: 15885629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.
    Kordower JH; Olanow CW; Dodiya HB; Chu Y; Beach TG; Adler CH; Halliday GM; Bartus RT
    Brain; 2013 Aug; 136(Pt 8):2419-31. PubMed ID: 23884810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental Lewy body disease and preclinical Parkinson disease.
    DelleDonne A; Klos KJ; Fujishiro H; Ahmed Z; Parisi JE; Josephs KA; Frigerio R; Burnett M; Wszolek ZK; Uitti RJ; Ahlskog JE; Dickson DW
    Arch Neurol; 2008 Aug; 65(8):1074-80. PubMed ID: 18695057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of GBA variants in Lewy body disease neuropathology.
    Walton RL; Koga S; Beasley AI; White LJ; Griesacker T; Murray ME; Kasanuki K; Hou X; Fiesel FC; Springer W; Uitti RJ; Fields JA; Botha H; Ramanan VK; Kantarci K; Lowe VJ; Jack CR; Ertekin-Taner N; Savica R; Graff-Radford J; Petersen RC; Parisi JE; Reichard RR; Graff-Radford NR; Ferman TJ; Boeve BF; Wszolek ZK; Dickson DW; Ross OA; Heckman MG
    Acta Neuropathol; 2024 Mar; 147(1):54. PubMed ID: 38472443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nigral Pathology Contributes to Microstructural Integrity of Striatal and Frontal Tracts in Parkinson's Disease.
    Lin CP; Knoop LEJ; Frigerio I; Bol JGJM; Rozemuller AJM; Berendse HW; Pouwels PJW; van de Berg WDJ; Jonkman LE
    Mov Disord; 2023 Sep; 38(9):1655-1667. PubMed ID: 37347552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A neuropathological study of the disturbance of the nigro-amygdaloid connections in brains from patients with dementia with Lewy bodies.
    Iseki E; Kato M; Marui W; Uéda K; Kosaka K
    J Neurol Sci; 2001 Apr; 185(2):129-34. PubMed ID: 11311294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nigro-striatal and nigro-amygdaloid pathways undergo different degeneration processes in brains of dementia with Lewy bodies.
    Iseki E; Marui W; Yamamoto R; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
    Neurosci Lett; 2005 May 20-27; 380(1-2):161-5. PubMed ID: 15854770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences for clinical correlates of substantia nigra neuron loss in people with Lewy body pathology.
    Bayram E; Coughlin DG; Rajmohan R; Litvan I
    Biol Sex Differ; 2024 Jan; 15(1):8. PubMed ID: 38243325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism.
    Hauser MA; Li YJ; Xu H; Noureddine MA; Shao YS; Gullans SR; Scherzer CR; Jensen RV; McLaurin AC; Gibson JR; Scott BL; Jewett RM; Stenger JE; Schmechel DE; Hulette CM; Vance JM
    Arch Neurol; 2005 Jun; 62(6):917-21. PubMed ID: 15956162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers.
    Beach TG; Walker DG; Sue LI; Newell A; Adler CC; Joyce JN
    J Neuropathol Exp Neurol; 2004 Apr; 63(4):329-37. PubMed ID: 15099023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inconsistency between severe substantia nigra degeneration with Lewy bodies and clinical parkinsonism in dementia patients: a cliniconeuropathological study.
    Ala TA; Yang KH; Sung JH; Frey WH
    Acta Neuropathol; 2000 May; 99(5):511-6. PubMed ID: 10805094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An order in Lewy body disorders: Retrograde degeneration in hyperbranching axons as a fundamental structural template accounting for focal/multifocal Lewy body disease.
    Uchihara T
    Neuropathology; 2017 Apr; 37(2):129-149. PubMed ID: 27862327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.
    Dickson DW; Fujishiro H; DelleDonne A; Menke J; Ahmed Z; Klos KJ; Josephs KA; Frigerio R; Burnett M; Parisi JE; Ahlskog JE
    Acta Neuropathol; 2008 Apr; 115(4):437-44. PubMed ID: 18264713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nigrostriatal tau pathology in parkinsonism and Parkinson's disease.
    Chu Y; Hirst WD; Federoff HJ; Harms AS; Stoessl AJ; Kordower JH
    Brain; 2024 Feb; 147(2):444-457. PubMed ID: 38006313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of Alzheimer-type pathology to dementia in Parkinson's disease.
    Jendroska K
    J Neural Transm Suppl; 1997; 49():23-31. PubMed ID: 9266411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy Bodies.
    Moors TE; Paciotti S; Ingrassia A; Quadri M; Breedveld G; Tasegian A; Chiasserini D; Eusebi P; Duran-Pacheco G; Kremer T; Calabresi P; Bonifati V; Parnetti L; Beccari T; van de Berg WDJ
    Mol Neurobiol; 2019 Feb; 56(2):1344-1355. PubMed ID: 29948939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.